Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs
Fang, Fang, Cardenas, Horacio, Huang, Hao, Jiang, Guanglong, Perkins, Susan M, Zhang, Chi, Keer, Harold N, Liu, Yunlong, Nephew, Kenneth P, Matei, Daniela
Published in Cancer research (Chicago, Ill.) (01.02.2018)
Published in Cancer research (Chicago, Ill.) (01.02.2018)
Get full text
Journal Article
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations
Pulliam, Nicholas, Fang, Fang, Ozes, Ali R, Tang, Jessica, Adewuyi, Adeoluwa, Keer, Harold, Lyons, John, Baylin, Stephen B, Matei, Daniela, Nakshatri, Harikrishna, Rassool, Feyruz V, Miller, Kathy D, Nephew, Kenneth P
Published in Clinical cancer research (01.07.2018)
Published in Clinical cancer research (01.07.2018)
Get full text
Journal Article
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients
Jahn, Ekaterina, Saadati, Maral, Fenaux, Pierre, Gobbi, Marco, Roboz, Gail J., Bullinger, Lars, Lutsik, Pavlo, Riedel, Anna, Plass, Christoph, Jahn, Nikolaus, Walter, Claudia, Holzmann, Karlheinz, Hao, Yong, Naim, Sue, Schreck, Nicholas, Krzykalla, Julia, Benner, Axel, Keer, Harold N., Azab, Mohammad, Döhner, Konstanze, Döhner, Hartmut
Published in Leukemia (01.11.2023)
Published in Leukemia (01.11.2023)
Get full text
Journal Article
Methylomic Signatures of High Grade Serous Ovarian Cancer
Cardenas, Horacio, Fang, Fang, Jiang, Guanglong, Perkins, Susan M., Zhang, Chi, Emerson, Robert E., Hutchins, George, Keer, Harold N., Liu, Yunlong, Matei, Daniela, Nephew, Kenneth
Published in Epigenetics (02.11.2021)
Published in Epigenetics (02.11.2021)
Get full text
Journal Article
Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients
Jahn, Ekaterina, Saadati, Maral, Fenaux, Pierre, Gobbi, Marco, Roboz, Gail J., Bullinger, Lars, Lutsik, Pavlo, Riedel, Anna, Plass, Christoph, Jahn, Nikolaus, Walter, Claudia, Holzmann, Karlheinz, Hao, Yong, Naim, Sue, Schreck, Nicholas, Krzykalla, Julia, Benner, Axel, Keer, Harold N., Azab, Mohammad, Döhner, Konstanze, Döhner, Hartmut
Published in Leukemia (01.11.2023)
Published in Leukemia (01.11.2023)
Get full text
Journal Article
Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer
Shah, Manish A, Wainberg, Zev A, Catenacci, Daniel V T, Hochster, Howard S, Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C, Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P
Published in PloS one (14.03.2013)
Published in PloS one (14.03.2013)
Get full text
Journal Article
Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Seiwert, Tanguy, Sarantopoulos, John, Kallender, Howard, McCallum, Stewart, Keer, Harold N., Blumenschein, George
Published in Investigational new drugs (01.04.2013)
Published in Investigational new drugs (01.04.2013)
Get full text
Journal Article
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial
Garcia-Manero, Guillermo, Roboz, Gail, Walsh, Katherine, Kantarjian, Hagop, Ritchie, Ellen, Kropf, Patricia, O'Connell, Casey, Tibes, Raoul, Lunin, Scott, Rosenblat, Todd, Yee, Karen, Stock, Wendy, Griffiths, Elizabeth, Mace, Joseph, Podoltsev, Nikolai, Berdeja, Jesus, Jabbour, Elias, Issa, Jean-Pierre J, Hao, Yong, Keer, Harold N, Azab, Mohammad, Savona, Michael R
Published in The Lancet. Haematology (01.06.2019)
Published in The Lancet. Haematology (01.06.2019)
Get more information
Journal Article
A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of c-Met and Vascular Endothelial Growth Factor Receptor 2
EDER, Joseph Paul, SHAPIRO, Geoffrey I, MCCALLUM, Stewart, HEATH, Elisabeth I, BOERNER, Scott A, LORUSSO, Patricia M, APPLEMAN, Leonard J, ZHU, Andrew X, MILES, Dale, KEER, Harold, CANCILLA, Belinda, CHU, Felix, HITCHCOCK-BRYAN, Suzanne, SHERMAN, Laurie
Published in Clinical cancer research (01.07.2010)
Published in Clinical cancer research (01.07.2010)
Get full text
Journal Article
Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
Thakar, Manjusha, Hu, Yue, Morreale, Michael, Lerner, Lane, Lin, Wan Ying, Sen, Rupashree, Cai, Yi, Karunasena, Enusha, Thakar, Maya, Saggi, Soren, Keer, Harold, Ahuja, Nita
Published in PloS one (20.11.2020)
Published in PloS one (20.11.2020)
Get full text
Journal Article
A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
Thakar, Manjusha, Hu, Yue, Morreale, Michael, Lerner, Lane, Ying Lin, Wan, Sen, Rupashree, Cai, Yi, Karunasena, Enusha, Thakar, Maya, Saggi, Soren, Keer, Harold, Ahuja, Nita
Published in PloS one (21.06.2018)
Published in PloS one (21.06.2018)
Get full text
Journal Article
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
Shah, Manish A., Wainberg, Zev A., Catenacci, Daniel V. T., Hochster, Howard S., Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C., Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P.
Published in PloS one (10.10.2022)
Published in PloS one (10.10.2022)
Get full text
Journal Article
PB2021: PHASE 2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH MAGROLIMAB FOR PREVIOUSLY UNTREATED SUBJECTS WITH INTERMEDIATE TO VERY HIGH‐RISK MYELODYSPLASTIC SYNDROMES (MDS)
Zeidan, Amer M., Mosher, Karen, Souza, Sonia, Mirakhur, Beloo, Keer, Harold, Taylor, Jason
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
Riess, Jonathan W, Reckamp, Karen L, Frankel, Paul, Longmate, Jeffrey, Kelly, Karen A, Gandara, David R, Weipert, Caroline M, Raymond, Victoria M, Keer, Harold N, Mack, Philip C, Newman, Edward M, Lara, Primo N
Published in Clinical lung cancer (01.11.2021)
Published in Clinical lung cancer (01.11.2021)
Get full text
Journal Article
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
Shah, Manish A, Wainberg, Zev A, Catenacci, Daniel V T, Hochster, Howard S, Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C, Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P
Published in PloS one (23.12.2021)
Published in PloS one (23.12.2021)
Get full text
Journal Article
Real‐world study of the use of azacitidine in myelodysplasia in Australia
Enjeti, Anoop, Ashraf, Asma, Caillet, Vincent, Alam, Arif, Silar, Jonathan, Keer, Harold, Castaldi, Francesco, Paine, Taleisha
Published in EJHaem (01.06.2024)
Published in EJHaem (01.06.2024)
Get full text
Journal Article
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
Garcia-Manero, Guillermo, McCloskey, James, Griffiths, Elizabeth A, Yee, Karen W L, Zeidan, Amer M, Al-Kali, Aref, Deeg, H Joachim, Patel, Prapti A, Sabloff, Mitchell, Keating, Mary-Margaret, Zhu, Nancy, Gabrail, Nashat Y, Fazal, Salman, Maly, Joseph, Odenike, Olatoyosi, Kantarjian, Hagop, DeZern, Amy E, O'Connell, Casey L, Roboz, Gail J, Busque, Lambert, Buckstein, Rena, Amin, Harshad, Randhawa, Jasleen, Leber, Brian, Shastri, Aditi, Dao, Kim-Hien, Oganesian, Aram, Hao, Yong, Keer, Harold N, Azab, Mohammad, Savona, Michael R
Published in The Lancet. Haematology (01.01.2024)
Published in The Lancet. Haematology (01.01.2024)
Get more information
Journal Article
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial
Roboz, Gail J., Sanz, Guillermo, Griffiths, Elizabeth A., Yee, Karen, Kantarjian, Hagop, Récher, Christian, Byrne, Michael T., Patkowska, Elżbieta, Kim, Hee-Je, Thomas, Xavier, Moors, Ine, Stock, Wendy, Illés, Árpád, Fenaux, Pierre, Miyazaki, Yasushi, Yamauchi, Takahiro, O'Connell, Casey L., Hao, Yong, Keer, Harold N., Azab, Mohammad, Döhner, Hartmut
Published in Blood advances (23.04.2024)
Published in Blood advances (23.04.2024)
Get full text
Journal Article
PB2358: PHASE 1‐2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL
Shortt, Jake, Poligone, Brian, Ribrag, Vincent, Zinzani, Pier Luigi, El‐Sharkawi, Dima, Walewski, Jan, Prica, Anca, Wilson, Laksmi, Souza, Sonia, Keer, Harold, Taylor, Jason, Marchi, Enrica
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Fenaux, Pierre, Gobbi, Marco, Kropf, Patricia L., Issa, Jean-Pierre J., Roboz, Gail J., Mayer, Jiri, Krauter, Jürgen, Robak, Tadeusz, Kantarjian, Hagop, Novak, Jan, Jedrzejczak, W. W., Thomas, Xavier, Ojeda-Uribe, Mario, Miyazaki, Yasushi, Min, Yoo Hong, Yeh, Su-Peng, Brandwein, Joseph, Gercheva-Kyuchukova, Liana, Demeter, Judit, Griffiths, Elizabeth, Yee, Karen, Döhner, Konstanze, Hao, Yong, Keer, Harold, Azab, Mohammad, Döhner, Hartmut
Published in Blood advances (12.09.2023)
Published in Blood advances (12.09.2023)
Get full text
Journal Article